wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26738598-5EFBF7DE-2783-4C93-BCC0-6580F34266E3
Q26738598-5EFBF7DE-2783-4C93-BCC0-6580F34266E3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738598-5EFBF7DE-2783-4C93-BCC0-6580F34266E3
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
P2860
Q26738598-5EFBF7DE-2783-4C93-BCC0-6580F34266E3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738598-5EFBF7DE-2783-4C93-BCC0-6580F34266E3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6e7f35ddff3606df2dc4077526fb199bc18f51bb
P2860
Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group.